Clinical trials
Phase 1/2 Uterine Cervical Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
135 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 5 |
| 2003 | 4 |
| 2004 | 1 |
| 2005 | 1 |
| 2007 | 2 |
| 2008 | 2 |
| 2009 | 1 |
| 2010 | 5 |
| 2012 | 2 |
| 2013 | 4 |
| 2014 | 4 |
| 2015 | 6 |
| 2016 | 3 |
| 2017 | 8 |
| 2018 | 5 |
| 2019 | 7 |
| 2020 | 10 |
| 2021 | 9 |
| 2022 | 10 |
| 2023 | 16 |
| 2024 | 10 |
| 2025 | 12 |
| 2026 | 6 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 49 |
| Recruiting | 33 |
| Terminated | 22 |
| Active, not recruiting | 12 |
| Unknown status | 8 |
| Withdrawn | 5 |
| Not yet recruiting | 5 |
| Suspended | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 10 |
| University Health Network, Toronto | 4 |
| Cancer Research UK | 3 |
| Genmab | 3 |
| Incyte Biosciences International Sàrl | 3 |
| Peking Union Medical College Hospital | 3 |
| Agenus Inc. | 2 |
| Evopoint Biosciences Inc. | 2 |
| Fuda Cancer Hospital, Guangzhou | 2 |
| Klus Pharma Inc. | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Uterine Cervical Neoplasms | 135 |
| Ovarian Neoplasms | 44 |
| Carcinoma, Non-Small-Cell Lung | 37 |
| Endometrial Neoplasms | 37 |
| Squamous Cell Carcinoma of Head and Neck | 29 |
| Esophageal Neoplasms | 26 |
| Stomach Neoplasms | 26 |
| Melanoma | 24 |
| Breast Neoplasms | 23 |
| Head and Neck Neoplasms | 20 |
Trials
Showing 26 to 50 of 135. Each trial links to its page on Pharma Observatory.
35 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.